Is Repligen Corporation (RGEN) A Good Stock To Buy Now?
Is RGEN a good stock to buy? We came across a bullish thesis on Repligen Corporation on R. Dennis’s Substack by OppCost.
Posts Tagged ‘NASDAQ:RGEN’
Here’s Why Repligen Corp. (RGEN) Fell 28% in Q1
TimesSquare Capital Management, an equity investment management company, released its “U.S.
Repligen Corporation (RGEN) Dropped Following the Earnings Release
Brown Capital Management, an investment management company, released its first quarter 2026 investor letter for “The Brown Capital Management Small Company Fund”.
Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools
Osterweis Capital Management, an investment management firm, released its Q1 2026 investor update for its “Osterweis Opportunity Fund”.
Billionaire Lee Ainslie’s 10 Stocks with Huge Upside Potential
There is more greed than fear, going by the blockbuster gains in the equity markets following the US-Iran war-triggered correction in March.
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
On April 30, Bloomberg reported that Steve Cohen resigned as president of Point72 Asset Management, and Harry Schwefel was appointed co-CIO.
Repligen Corporation (NASDAQ:RGEN) Q1 2026 Earnings Call Transcript
Repligen Corporation (NASDAQ:RGEN) Q1 2026 Earnings Call Transcript May 5, 2026Repligen Corporation beats earnings expectations.
Tempered Forward Expectations Hurt Repligen Corp. (RGEN) in Q1
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Here’s What Positioned Repligen Corporation (RGEN) for a Durable Long-Term Growth
Fred Alger Management, an investment management company, released its “Alger Mid Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here...
Repligen Corporation (NASDAQ:RGEN) Q4 2025 Earnings Call Transcript
Repligen Corporation (NASDAQ:RGEN) Q4 2025 Earnings Call Transcript February 24, 2026Repligen Corporation beats earnings expectations.
Repligen Corp. (RGEN) Rose as Industrial Destocking Decreased and Order Patterns Stabilized
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with...
What Makes Repligen Corporation (RGEN) an Investment Choice?
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here.
UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds
Repligen Corporation (NASDAQ:RGEN) is one of the best mid-cap growth stocks to buy right now.
14 Best Mid-Cap Growth Stocks to Buy Right Now
On January 8, Nancy Prial, Co-CEO & Senior Portfolio Manager at Essex Investment Management, appeared on CNBC and suggested she sees significant upside in 2026 for undiscovered...
Here’s Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN)
Sands Capital, an investment management company, released its “Sands Capital Global Growth Fund” third-quarter 2025 investor letter.
Is Repligen (RGEN) The Best Healthcare Stock to Buy Now?
Dan Veru, Palisade Capital Management senior partner and CIO, recently talked about Repligen, a life sciences company involved in the development and production of materials used...
Top 10 Stock Recommendations You Can’t Miss Amid Growing AI Bubble Fears
Blockbuster AI deals with eye-popping numbers have started to make Wall Street uneasy amid growing concerns about stock valuations and parallels between today’s AI boom and ...
Repligen Corporation (NASDAQ:RGEN) Q2 2025 Earnings Call Transcript
Repligen Corporation (NASDAQ:RGEN) Q2 2025 Earnings Call Transcript July 29, 2025Repligen Corporation misses on earnings expectations.
Does Repligen Corp (RGEN) Have a Strong Pricing Power?
Prosper Stars & Stripes, a long/short equity fund, recently released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years
“This week we're celebrating the show's 20th anniversary, a little over a month late, but better late than never.
Repligen Corporation (NASDAQ:RGEN) Q1 2025 Earnings Call Transcript
Repligen Corporation (NASDAQ:RGEN) Q1 2025 Earnings Call Transcript April 29, 2025Repligen Corporation beats earnings expectations.
Top 10 Stocks to Buy According to 12 West Capital Management
Joel Ramin founded 12 West Capital Management in August 2011, establishing it as a New York-based hedge fund specializing in global investments across equities, equity-related...
Repligen Corporation (NASDAQ:RGEN) Q4 2024 Earnings Call Transcript
Repligen Corporation (NASDAQ:RGEN) Q4 2024 Earnings Call Transcript February 20, 2025Repligen Corporation beats earnings expectations.
Repligen Corporation (RGEN) Fell Along with Peers
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” third quarter 2024 investor letter. A copy of the...
Several Factors Lifted Repligen Corporation (RGEN) in Q3
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter.
Repligen Corporation (NASDAQ:RGEN) Q3 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Repligen Corporation's Third Quarter of 2024 Earnings Conference Call.
Several Headwinds Dragged Repligen Corporation (RGEN) in Q2
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its second quarter 2024 investor letter. A copy of the fund can be downloaded here.
Reasons for the Decline of Repligen (RGEN) in Q2
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter.
Repligen Corporation (RGEN) Fell Due to CEO Transition
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Fund” second quarter 2024 investor letter.
Repligen Corporation (RGEN) Benefitted From Drug Approval
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)?
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” second-quarter 2024 investor letter.
Repligen Corporation (NASDAQ:RGEN) Q2 2024 Earnings Call Transcript
Repligen Corporation (NASDAQ:RGEN) Q2 2024 Earnings Call Transcript July 30, 2024Repligen Corporation misses on earnings expectations.
Should You Consider Investing in Repligen Corporation (RGEN)?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” second-quarter 2024 investor letter.
20 Most Profitable Stocks of the Last 20 Years
The stock market has a long history of generating wealth for investors.
Here’s Why Baron Discovery Fund Sold Repligen Corporation (RGEN)
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
Repligen Corporation misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.29.
Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript
Repligen Corporation reports earnings inline with expectations. Reported EPS is $0.33 EPS, expectations were $0.33.
Here’s Why Repligen Corporation (RGEN) Rose 13% in Q3
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter.
Does Repligen Corp. (RGEN) Have a Bright Future?
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” third-quarter 2023 investor letter.
Repligen Corporation (NASDAQ:RGEN) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Repligen’s 2023 Third Quarter Earnings Conference Call. My name is Keith, and I will be your coordinator.
Reasons For the Decline of Repligen Corporation (RGEN)
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second quarter 2023 investor letter.
What Makes Repligen Corporation (RGEN) a Quality Investment?
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Multiple Headwinds Impacted Repligen Corp. (RGEN)’s Performance in Q2
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” second-quarter 2023 investor letter.
Repligen Corporation (NASDAQ:RGEN) Q2 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Repligen Corporation Second Quarter of 2023 Earnings Conference Call.
Repligen Corporation (NASDAQ:RGEN) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Repligen First Quarter of 2023 Earnings Conference Call. My name is Vaishnavi, and I will be your coordinator.
Is Repligen Corporation (RGEN) a Best-In-Class Stock in Terms of Growth and Profitability?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Repligen Corporation's Fourth Quarter of 2022 Earnings Conference Call.
Hedge Fund Resource Center
